摘要
人类拓扑异构酶IB是一个重要的目标,在癌症的治疗和药物的选择性稳定拓扑异构酶ib-dna共价复合物在几种类型的癌症的临床应用。酪氨酰- DNA磷酸二酯酶1参与DNA的修复解决拓扑异构酶ib-dna共价复合物,对细胞的生存是非常危险的因为它产生不可逆的DNA损伤。由于这两种酶之间的密切的生物学关系,协同抑制剂,称为双抑制剂的发展,是一个重要的挑战,在癌症治疗和计算机辅助药物设计可能有助于识别的最佳化合物。在本综述中,概述了抑制两种酶之一或作为双抑制剂的化合物的概述。此外,对虚拟筛选方法的一般程序,提供了一种描述两种广泛使用的开源程序,即被描述的AutoDock4和AutoDock Vina。最后,一个应用程序的两个项目选定数量的双重抑制剂酪氨酸DNA磷酸二酯酶1和拓扑异构酶IB及其性能进行了简要的讨论。
关键词: AutoDock4,AutoDock Vina,双重抑制剂,indenoisoquinolines,分子对接,拓扑异构酶IB,酪氨酰- DNA磷酸二酯酶,虚拟筛选。
图形摘要
Current Drug Targets
Title:Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1
Volume: 18 Issue: 5
关键词: AutoDock4,AutoDock Vina,双重抑制剂,indenoisoquinolines,分子对接,拓扑异构酶IB,酪氨酰- DNA磷酸二酯酶,虚拟筛选。
摘要: Human topoisomerase IB is an important target in cancer therapy and drugs selectively stabilizing the topoisomerase IB-DNA covalent complex are in clinical use for several cancer types. Tyrosyl- DNA phosphodiesterase 1 is involved in the DNA repair resolving the topoisomerase IB-DNA covalent complex that is extremely dangerous for the survival of the cells since it produces an irreversible DNA damage. Given the close biological relationship between these two enzymes, the development of synergistic inhibitors, called dual-inhibitors, is an important challenge in cancer therapy and computer-aided drug design may help in the identification of the best compounds. In this review, an overview of the compounds inhibiting one of the two enzymes or acting as dual inhibitors is provided. Moreover, the general procedures of the virtual screening approach, providing a description of two widely used opensource programs, namely AutoDock4 and AutoDock Vina, are described. Finally, an application of the two programs on a selected number of dual inhibitors for tyrosyl-DNA phosphodiesterase 1 and topoisomerase IB and their performance is briefly discussed.
Export Options
About this article
Cite this article as:
Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1, Current Drug Targets 2017; 18 (5) . https://dx.doi.org/10.2174/1389450116666150727114742
DOI https://dx.doi.org/10.2174/1389450116666150727114742 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Medicinal Chemistry of Alternative Therapeutics: Novelty and Hopes with Genus Ammannia
Current Topics in Medicinal Chemistry Discovery of Lansoprazole and its Unique Pharmacological Properties Independent from Anti-secretory Activity
Current Pharmaceutical Design Drug Metabolism and Drug Interactions: Application and Clinical Value of In Vitro Models
Current Drug Metabolism Concepts for Nano-delivery of Therapeutic Immunomodulatory Agents
Current Bionanotechnology (Discontinued) Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Curcumin Nanomedicine: A Road to Cancer Therapeutics
Current Pharmaceutical Design Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets A General Approach on Surfactants Use and Properties in Drug Delivery Systems
Current Pharmaceutical Design Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Solid Lipid Nanoparticles: A Potential Approach for Drug Delivery System
Nanoscience & Nanotechnology-Asia Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from <i>Nigella sativa</i> L. that Inhibit Cag A and Vac A Oncoprotein of <i>Helicobacter pylori</i>: Probable Treatment of <i>H. pylori</i> Infections
Medicinal Chemistry Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Current Cancer Drug Targets Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Current Drug Targets Cucurbitacins as Inducers of Cell Death and a Rich Source of Potential Anticancer Compounds
Current Pharmaceutical Design EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?
Current Drug Targets Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Current Pharmaceutical Design Interpreting the Mechanisms by which Integrins Promote the Differentiation of Mesenchymal Stem Cells and Integrin Application Prospects
Current Stem Cell Research & Therapy Induction of Apoptosis via the Modulation of Reactive Oxygen Species (ROS) Production in the Treatment of Myeloid Leukemia
Current Pharmaceutical Biotechnology Recent Progress in Phosphoinositide 3-Kinases: Oncogenic Properties and Prognostic and Therapeutic Implications
Current Protein & Peptide Science Novel Somatic Mutations of the CDH1 Gene Associated with Gastric Cancer: Prediction of Pathogenicity Using Comprehensive In silico Methods
Current Pharmacogenomics and Personalized Medicine